Jove
Visualize
Contact Us

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.2K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

22
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
22
Fischer Projections02:18

Fischer Projections

14.3K
Learning to draw Fischer projections of molecules and understanding their relevance plays a crucial role in the visual depiction of organic molecules. A Fischer projection is a two-dimensional projection on a planar surface to simplify the three-dimensional wedge–dash representation of molecules. This is especially helpful in the case of molecules with multiple chiral centers that can be difficult to draw. Here, all the bonds of interest are represented as horizontal or vertical lines.
14.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ANARCII enables alignment-free antigen receptor numbering using a generalised language model.

Communications biology·2026
Same author

iNOS modulates inflammatory responses in an NO-independent manner through direct interaction with IRG1 in mitochondria.

Nature metabolism·2026
Same author

Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.

mAbs·2026
Same author

LICHEN enables light-chain immunoglobulin sequence generation conditioned on the heavy chain and experimental needs.

Communications biology·2026
Same author

The Heterocycle Isostere Explorer: A Computational Tool for the Discovery of Novel Aromatic Heterocyclic Isosteres.

Journal of medicinal chemistry·2026
Same author

Characterising nanobody developability to improve therapeutic design using the Therapeutic Nanobody Profiler.

Communications biology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Oct 10, 2025

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

8.8K

Deep generative design with 3D pharmacophoric constraints.

Fergus Imrie1, Thomas E Hadfield1, Anthony R Bradley2

  • 1Oxford Protein Informatics Group, Department of Statistics, University of Oxford Oxford OX1 3LB UK deane@stats.ox.ac.uk.

Chemical Science
|December 9, 2021
PubMed
Summary

This study introduces DEVELOP, a generative model for molecular design that uses 3D structural information. This approach enhances molecular generation quality and control, significantly improving drug discovery processes.

More Related Videos

Multimodal 3D Printing of Phantoms to Simulate Biological Tissue
05:11

Multimodal 3D Printing of Phantoms to Simulate Biological Tissue

Published on: January 11, 2020

7.7K
3D Printing of Biomolecular Models for Research and Pedagogy
09:17

3D Printing of Biomolecular Models for Research and Pedagogy

Published on: March 13, 2017

24.3K

Related Experiment Videos

Last Updated: Oct 10, 2025

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

8.8K
Multimodal 3D Printing of Phantoms to Simulate Biological Tissue
05:11

Multimodal 3D Printing of Phantoms to Simulate Biological Tissue

Published on: January 11, 2020

7.7K
3D Printing of Biomolecular Models for Research and Pedagogy
09:17

3D Printing of Biomolecular Models for Research and Pedagogy

Published on: March 13, 2017

24.3K

Area of Science:

  • Computational Chemistry
  • Drug Discovery
  • Artificial Intelligence in Chemistry

Background:

  • Generative models are proposed for molecular design but struggle with control and incorporating prior knowledge.
  • Current methods often neglect crucial three-dimensional (3D) structural information vital for molecular binding.
  • Limited use of 3D structural data hinders practical applications in drug discovery.

Purpose of the Study:

  • To develop a generative model that effectively incorporates 3D structural information for molecular design.
  • To demonstrate the benefits of using 3D pharmacophoric information in generative models.
  • To enhance control and quality in molecular generation for drug discovery.

Main Methods:

  • Combined DeLinker, a graph-based deep generative model, with a convolutional neural network.
  • Utilized physically-meaningful 3D representations of molecules and target pharmacophores.
  • Applied the developed model, DEVELOP, to linker and R-group design tasks.

Main Results:

  • Incorporating 3D pharmacophoric information improved molecular generation quality and control.
  • Achieved over 300% improvement in generating molecules with high 3D similarity on a PDBbind test set.
  • The DEVELOP model recovered 10x more original molecules compared to the baseline DeLinker method.

Conclusions:

  • The developed method, DEVELOP, effectively integrates 3D structural information into generative molecular design.
  • 3D pharmacophoric constraints substantially enhance the quality and similarity of generated molecules.
  • The general-purpose approach is adaptable and can be integrated into various generative frameworks for drug discovery.